- Home
- PDSB vs LTRN Comparison
PDSB vs LTRN Comparison
Compare PDSB & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- LTRN
- Stock Information
- Founded
- PDSB 2005
- LTRN 2013
- Country
- PDSB United States
- LTRN United States
- Employees
- PDSB N/A
- LTRN N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- PDSB Health Care
- LTRN Health Care
- Exchange
- PDSB Nasdaq
- LTRN Nasdaq
- Market Cap
- PDSB 44.5M
- LTRN 49.9M
- IPO Year
- PDSB N/A
- LTRN 2020
- Fundamental
- Price
- PDSB $0.94
- LTRN $4.16
- Analyst Decision
- PDSB Strong Buy
- LTRN Strong Buy
- Analyst Count
- PDSB 2
- LTRN 1
- Target Price
- PDSB $10.00
- LTRN $25.00
- AVG Volume (30 Days)
- PDSB 489.6K
- LTRN 173.4K
- Earning Date
- PDSB 11-13-2025
- LTRN 11-14-2025
- Dividend Yield
- PDSB N/A
- LTRN N/A
- EPS Growth
- PDSB N/A
- LTRN N/A
- EPS
- PDSB N/A
- LTRN N/A
- Revenue
- PDSB N/A
- LTRN N/A
- Revenue This Year
- PDSB N/A
- LTRN N/A
- Revenue Next Year
- PDSB N/A
- LTRN N/A
- P/E Ratio
- PDSB N/A
- LTRN N/A
- Revenue Growth
- PDSB N/A
- LTRN N/A
- 52 Week Low
- PDSB $0.85
- LTRN $2.55
- 52 Week High
- PDSB $3.48
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- PDSB 40.57
- LTRN 49.43
- Support Level
- PDSB $0.89
- LTRN $3.89
- Resistance Level
- PDSB $1.03
- LTRN $4.20
- Average True Range (ATR)
- PDSB 0.06
- LTRN 0.29
- MACD
- PDSB 0.00
- LTRN -0.04
- Stochastic Oscillator
- PDSB 31.67
- LTRN 42.85
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.